Ethos Financial Group, LLC

SEC CIK: 0001954242
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

NRXP holding history

NRX Pharmaceuticals, Inc. in every 13F filed by Ethos Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRXP overview All 13F holders of NRXP Full Q2 2026 holdings

Shares (Q2 2026): 15,900
Value: $51.4K
% of portfolio: <0.1%
Quarters held: 4; Since Q3 2025

Holdings of NRXP by Ethos Financial Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	15,900	$51.4K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	15,900	$33.9K	<0.1%	+4,000+33.6%	Added	Holders
Q4 2025	11,900	$32.2K	<0.1%	00.0%	Unchanged	Holders
Q3 2025	11,900	$39.3K	<0.1%	+11,900	New	Holders